Leader in Cannabinoid Medicine

About Us

OUR STORY SO FAR

CanniOasis: Personalized cannabinoid-based biopharma company from Singapore

Founded in 2021, CanniOasis has created a theragnostic platform for the development of precision cannabinoid-based drugs that includes state-of-the-art prognostic clinical testing and molecular mapping to guide the personalized treatment of neurological disorders. A key differentiator and competitive advantage for the Company is its midbrain organoid model that will substantially de-risk and shorten the drug development process for neurological disorders.

Advisory Team

Our Expert Advisors

Prof. Moshe Szyf

Scientific Advisor

Professor of Pharmacology and fellow of the Royal Society of Canada and the Canadian Academy of Health Sciences

Experience in diagnostics and therapeutics and founded the first Pharma in the world dedicated to DNA methylation drugs

Prof. Hyman Schipper

Scientific / Medical Advisor

MD and PHD (Neuroendocrinology)

Founding Director and scientist for Centre for Neurotranslational Research and Molecular Biometrics Inc

Expert in oxidative stress, brain aging and neurodegenerative diseases

Prof. Peter Lim

Independent Director

Medical Director of Andrology, Urology & Continence (Gleneagles H)

Professor at Cowen University, Australia and Honorary Professor at HT Naval Medical School, Indonesia

Novanne Seah

Co-Founder / Director

Accomplished professional with expertise in nutri-pharmaceuticals and biomedicine

Director of several biotech companies incl. Gene Oasis, Zenzic Labs and Green Oasis Therapeutics

Chairman of ER Therapeutics, a listed company in China focusing on Endoplasmic Reticulum Biomedicine

The Management Team

Our awesome team members

Dr Lim Kah Meng

Founder / Non-Executive Chairman / Chief Scientific Advisor

Experienced scientist in the biotechnology and biopharmaceutical industry

Started his career as a Research Scientist in A*Star and as a Professor in NTU before venturing as an entrepreneur and advisor to several biotech companies

Currently serving as Independent Director in a SGX listed company and Board director in several other biotech companies

Holds Ph.D. in Biomedicine from National University of Singapore

Dr Tan Jok Tin

Vice Chairman

More than 40 years of senior executive experience incl. Chairman of Creative Technology Ltd, Vice Chairman of China-Asia Economic Development Association, ex CEO of Singapore WTC, Royal Philips Electronics, China Electronics Corporations etc

Senior Advisor and independent director of China-Singapore Guangzhou Knowledge City and Susing Asset Management (China)

Jon Lim

CEO / Director

More than 20 years performing finance and business strategy in KLA, Agilent Technologies, Merrill Lynch, OCBC and HL Display, in the USA, Sweden, Germany, Switzerland, and the Asia Pacific region.

Served as a Professional Management Consultant (PMC) and a consultant of Intellectual Property Office of Singapore (IPOS)

Joshua Siow

CFO

More than 30 years of senior executive and board membership with exchange listed on TSX, Stock exchange Thailand and SGX

CA, CIA and CRM with a MBA

ISO 9000 Lead Auditor and is a member of Singapore Institute of Directors

Treasurer and Chair the Finance Committee at 365 Cancer Prevention Society

Alfred Tan

COO / Director

More than 20 years of experience in marketing, operations, training and consultancy in the health and wellness, lifestyle and E commerce industries

MBA and is a Certified Certified AGILE Practioner

Singapore Certified Management Consultant (SCMC)

Dr Ron Tan

Executive Scientific Partner

More than 17 years experience in clinical diagnostics innovation

OUR PARTNERS

We partner with leading institutions

We partner with companies of all sizes to make a difference in our field.

A*Star

Singapore's lead public sector agency that spearheads economic oriented research to advance scientific discovery and develop innovative technology

Learn More

Gene Oasis

Gene Oasis is a business group registered in Singapore specializing in the production of natural bioactive ingredients, innovative products and efficient delivery systems based on a strong portfolio of proprietary technologies/intellectual properties (IPs)

Learn More

WuXi AppTec

As a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the pharmaceutical and healthcare industry around the world to advance discoveries and deliver groundbreaking treatments to patients.

Learn More